Host: Jennifer Caudle, DO

Guest: Dustin Deming, MD

Dr Dustin Deming presents an overview of BRAF-mutant metastatic colorectal cancer (CRC). He reviews the incidence of and prognosis for BRAF-mutant metastatic CRC. Phenotypic characteristics and the molecular pathway associated with BRAF-mutant metastatic CRC are also discussed.

© 2021 Pfizer Inc. All rights reserved. PP-BCE-USA-0284 January 2021